Skip to content
easybpt
Browse topics

Medical oncology

Organ toxicity of systemic cancer therapy

Myelosuppression and G-CSF, alopecia, anthracycline and trastuzumab cardiotoxicity under the ESC 2022 cardio-oncology guideline, drug-induced pneumonitis, neuropathy, and renal, liver, ear, fertility and late effects.

Tier 1Condition

Written with AI assistance and fact-checked against the sources below. For exam study, not clinical decisions. How notes are made

3 questions10 flashcards

At a glance

  • Systemic therapy toxicity depends on the drug class, cumulative dose and the patient's organ reserve. Learn the classic pairings: anthracyclines and heart, bleomycin and lung, cisplatin and kidney, ear and nerve, taxanes and vinca alkaloids and nerve.
  • Myelosuppression is the commonest dose-limiting toxicity. Fever with neutropenia is an emergency: see Febrile neutropenia.
  • Targeted drugs and antibody-drug conjugates have their own patterns (VEGF inhibitors and hypertension, trastuzumab deruxtecan and pneumonitis). Checkpoint inhibitors cause immune-related adverse events, covered in a separate note on checkpoint inhibitor toxicity.

Loading the rest of the note…

Finished reading?

Test yourself on it:3 questions10 flashcards

Sources

Last updated
14 November 2026
What changed
  • 14 November 2026 Personal emails, About story and Australian-style copy

Send feedback

Type of feedback

The page you're on and your device type are attached automatically.